Hierarchical Affinities and a Bipartite Interaction Model for Estrogen Receptor Isoforms and Full-length Steroid Receptor Coactivator (SRC/p160) Family Members*
暂无分享,去创建一个
Neil J McKenna | Bert W O'Malley | Chi-Wai Wong | Barry Komm | B. Komm | C. Lyttle | N. McKenna | B. O’Malley | J. Wong | Chi-wai Wong | Jiemin Wong | C Richard Lyttle | Boris J Cheskis | B. Cheskis
[1] R J Fletterick,et al. Structure and specificity of nuclear receptor-coactivator interactions. , 1998, Genes & development.
[2] K. Horwitz,et al. Nuclear receptor conformation, coregulators, and tamoxifen-resistant breast cancer , 2000, Steroids.
[3] H Grøn,et al. Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[4] D. Edwards,et al. The Steroid Receptor Coactivator-1 Contains Multiple Receptor Interacting and Activation Domains That Cooperatively Enhance the Activation Function 1 (AF1) and AF2 Domains of Steroid Receptors* , 1998, The Journal of Biological Chemistry.
[5] B. Komm,et al. Structure-function evaluation of ER alpha and beta interplay with SRC family coactivators. ER selective ligands. , 2001, Biochemistry.
[6] Paul Tempst,et al. Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex , 1999, Nature.
[7] J. Font de Mora,et al. AIB1 Is a Conduit for Kinase-Mediated Growth Factor Signaling to the Estrogen Receptor , 2000, Molecular and Cellular Biology.
[8] N. McKenna,et al. Distinct steady-state nuclear receptor coregulator complexes exist in vivo. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[9] M. Montminy,et al. Role of CBP/P300 in nuclear receptor signalling , 1996, Nature.
[10] B. O’Malley,et al. Phosphorylation of Steroid Receptor Coactivator-1 , 2000, The Journal of Biological Chemistry.
[11] R. Evans,et al. Nuclear Receptor Coactivator ACTR Is a Novel Histone Acetyltransferase and Forms a Multimeric Activation Complex with P/CAF and CBP/p300 , 1997, Cell.
[12] J. Wong,et al. p300 Requires Its Histone Acetyltransferase Activity and SRC-1 Interaction Domain To Facilitate Thyroid Hormone Receptor Activation in Chromatin , 2000, Molecular and Cellular Biology.
[13] Thorsten Heinzel,et al. A CBP Integrator Complex Mediates Transcriptional Activation and AP-1 Inhibition by Nuclear Receptors , 1996, Cell.
[14] Neil J. McKenna,et al. Combinatorial Control of Gene Expression by Nuclear Receptors and Coregulators , 2002, Cell.
[15] David A. Agard,et al. The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen , 1998, Cell.
[16] M. Lazar,et al. The DRIP Complex and SRC-1/p160 Coactivators Share Similar Nuclear Receptor Binding Determinants but Constitute Functionally Distinct Complexes , 2000, Molecular and Cellular Biology.
[17] T. Willson,et al. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ , 1998, Nature.
[18] K. Yamamoto,et al. An Additional Region of Coactivator GRIP1 Required for Interaction with the Hormone-binding Domains of a Subset of Nuclear Receptors* , 1999, The Journal of Biological Chemistry.
[19] H. Erdjument-Bromage,et al. A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system. , 1998, Genes & development.
[20] C. Lyttle,et al. A Transcriptional Coactivator, Steroid Receptor Coactivator-3, Selectively Augments Steroid Receptor Transcriptional Activity* , 1998, The Journal of Biological Chemistry.
[21] Myles Brown,et al. Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated Transcription , 2000, Cell.
[22] B. O’Malley,et al. Steroid receptor coactivator-1 (SRC-1) enhances ligand-dependent and receptor-dependent cell-free transcription of chromatin. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[23] B. O’Malley,et al. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. , 1994, Annual review of biochemistry.
[24] R. Roeder,et al. Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[25] D. Fowlkes,et al. Peptide antagonists of the human estrogen receptor. , 1999, Science.
[26] R. Darnell,et al. Involvement of the TRAP220 component of the TRAP/SMCC coactivator complex in embryonic development and thyroid hormone action. , 2000, Molecular cell.
[27] O. Hermanson,et al. Nuclear receptor coregulators: multiple modes of modification , 2002, Trends in Endocrinology & Metabolism.
[28] Donald P. McDonnell,et al. The Opposing Transcriptional Activities of the Two Isoforms of the Human Progesterone Receptor Are Due to Differential Cofactor Binding , 2000, Molecular and Cellular Biology.
[29] M. Parker,et al. Molecular Determinants of the Estrogen Receptor-Coactivator Interface , 1999, Molecular and Cellular Biology.
[30] C. Glass,et al. Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators , 1998, Nature.
[31] P. Chambon,et al. Crystal structure of the human RXRα ligand‐binding domain bound to its natural ligand: 9‐cis retinoic acid , 2000 .
[32] R. Roeder,et al. The TRAP220 component of a thyroid hormone receptor- associated protein (TRAP) coactivator complex interacts directly with nuclear receptors in a ligand-dependent fashion. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[33] David M. Heery,et al. A signature motif in transcriptional co-activators mediates binding to nuclear receptors , 1997, Nature.